Gemcitabine vs cisplatin in patients with locally advanced head and neck cancer who are also receiving radiotherapy

Trial Profile

Gemcitabine vs cisplatin in patients with locally advanced head and neck cancer who are also receiving radiotherapy

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2012

At a glance

  • Drugs Gemcitabine (Primary) ; Cisplatin
  • Indications Head and neck cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Jun 2012 New trial record
    • 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 01 Jun 2011 Primary endpoint 'Progression-free-survival-duration' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top